LGM Pharma expands U.S. CDMO capacity with a $15M investment across Texas and Colorado. Explore what this means for domestic drug manufacturing. Read more.
Bionpharma Inc. has secured Abbreviated New Drug Application (ANDA) approval from the United States Food and Drug Administration for its generic version of Etravirine tablets, a second-line treatment for HIV-1. Developed in partnership with STEERLife, the formulation leverages the proprietary FragMelt continuous manufacturing platform to overcome the heat- and shear-sensitivity of the active pharmaceutical ingredient. […]